Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lanctôt

Showing results (1-10 of 360) with videos related to

Pageof 36
Sort By:
The Canadian Nurse|April 1, 1989
[A nurse directs CSAM (AIDS Committee Montreal). An interview with Lise Lanctôt, MN (adm), MAP]L Lanctôt
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 1, 1997
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementiaN Herrmann, K L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
International Journal of Geriatric Psychiatry|April 18, 2000
Donepezil for behavioural disorders associated with Lewy bodies: a case seriesK L Lanctôt, N Herrmann
Clinical Pharmacology and Therapeutics|December 1, 1995
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug eventsK L Lanctôt, C A Naranjo
Journal of Clinical Pharmacology|February 1, 1994
Computer-assisted evaluation of adverse events using a Bayesian approachK L Lanctôt, C A Naranjo
Journal of the American Geriatrics Society|August 26, 1998
Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patientsJ H Moss, K L Lanctôt
Ageing Research Reviews|February 5, 2011
Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's typeTanya Pinto, Krista L Lanctôt, Nathan Herrmann
Pageof 36

Showing results (1-10 of 360) with videos related to

Sort By:
Pageof 36
The Canadian Nurse|April 1, 1989
[A nurse directs CSAM (AIDS Committee Montreal). An interview with Lise Lanctôt, MN (adm), MAP]L Lanctôt
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 1, 1997
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementiaN Herrmann, K L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
International Journal of Geriatric Psychiatry|April 18, 2000
Donepezil for behavioural disorders associated with Lewy bodies: a case seriesK L Lanctôt, N Herrmann
Clinical Pharmacology and Therapeutics|December 1, 1995
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug eventsK L Lanctôt, C A Naranjo
Journal of Clinical Pharmacology|February 1, 1994
Computer-assisted evaluation of adverse events using a Bayesian approachK L Lanctôt, C A Naranjo
Journal of the American Geriatrics Society|August 26, 1998
Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patientsJ H Moss, K L Lanctôt
Ageing Research Reviews|February 5, 2011
Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's typeTanya Pinto, Krista L Lanctôt, Nathan Herrmann
Pageof 36